Histological and Immunohistochemical Analyses Used to Study Craniosynostosis in Pediatric Patients by Baadh, Palvir Kaur
The University of Akron
IdeaExchange@UAkron
Honors Research Projects The Dr. Gary B. and Pamela S. Williams HonorsCollege
Summer 2015
Histological and Immunohistochemical Analyses
Used to Study Craniosynostosis in Pediatric
Patients
Palvir Kaur Baadh
University of Akron Main Campus, pkb9@zips.uakron.edu
Please take a moment to share how this work helps you through this survey. Your feedback will be
important as we plan further development of our repository.
Follow this and additional works at: http://ideaexchange.uakron.edu/honors_research_projects
Part of the Biochemistry, Biophysics, and Structural Biology Commons, Cell and Developmental
Biology Commons, and the Diseases Commons
This Honors Research Project is brought to you for free and open access by The Dr. Gary B. and Pamela S. Williams
Honors College at IdeaExchange@UAkron, the institutional repository of The University of Akron in Akron, Ohio,
USA. It has been accepted for inclusion in Honors Research Projects by an authorized administrator of
IdeaExchange@UAkron. For more information, please contact mjon@uakron.edu, uapress@uakron.edu.
Recommended Citation
Baadh, Palvir Kaur, "Histological and Immunohistochemical Analyses Used to Study Craniosynostosis in Pediatric
Patients" (2015). Honors Research Projects. 180.
http://ideaexchange.uakron.edu/honors_research_projects/180
 1 
Histological and Immunohistochemical Analyses Used to Study 
Craniosynostosis in Pediatric Patients 
 
Palvir Baadh, Phillip McClellan, BS, Robin Jacquet, MS, Ananth Murthy, MD and 
William Landis, PhD 
 
 
The University of Akron, Akron, OH 
  
 
 
Abstract  
 
     Craniosynostosis is a condition in which one or more of the sutures of the 
skull grow together (fuse) earlier than normal in infants.  Sutures are large gaps 
located at the bony plates or joints of the head.  Craniosynostosis causes the 
skull to expand and grow in the direction of any normal open suture, creating 
craniofacial complications, such as drooping eyelids and abnormal intracranial 
pressure, head shape, or brain morphology.  This premature fusion or 
ossification of sutures affects approximately 300-500 live births in 1,000,000 
(Kolpakova-Hart et al., 2008) with considerable variation in phenotype, 
depending on which suture(s) is involved.  Corrective surgery can be performed 
to reshape the skull and eliminate the symptom(s) present in the infant.  There is 
no known cause of craniosynostosis or direct pattern of heritability from parent to 
affected infant and the condition can appear syndromically (associated with 
syndrome or condition) or non-syndromically.  However, the majority of cases 
reported are sporadic, non-syndromic cases, in which pediatric patients suffer 
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from premature fusion of only one suture (Levi et al., 2012).  In the current 
prospective study, histological and/or immunohistochemical analyses have been 
conducted on sagittal synostoses as well as patent (normal open suture) tissue 
from the skulls of three pediatric patients.  Patient surgeries were performed at 
Akron Children’s Hospital.  The studies were begun to understand more 
completely the underlying etiology and possible risk factors of non-syndromic 
craniosynostosis.  Histological staining, including toluidine blue, hematoxylin and 
eosin, and picrosirius red counterstained with alcian blue, has been performed 
for qualitatively describing tissue and cell architectural shapes and gross 
morphology.  Immunohistochemical analysis has also been performed to study 
the presence of osterix, a transcription factor essential for osteoblast 
differentiation and bone formation.  Analytical results of this work are ongoing.   
 
Introduction 
     Craniosynostosis may affect any of the bones of the human skull. 
Eight bones form the neurocranium, which is sometimes referred to as the 
braincase.  These bones include the single frontal, occipital, sphenoid, and 
ethmoid bones and two parietal and temporal bones.  These bones together form 
the protective case around the brain.  The ossification of these flat bones of the 
skull occurs when mesenchymal cells differentiate into bone cells (osteoblasts) 
through intramembranous ossification, that is, ossification that occurs from 
fibrous membranes (Levi et al., 2012).  These bones are integrated and unified; 
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yet conversely separated by fibrous sutures, where the different bone plates 
meet.   
     The skull of an infant has four sutures, which include the metopic, coronal, 
sagittal, and the lambdoid suture.  The metopic suture is located where the two 
frontal bones on both sides of the skull meet.  This suture extends from the top of 
the head to the middle of the forehead.  The coronal suture occurs where each 
frontal bone meets the parietal bones on both sides of the head.  This suture 
extends from left-most side of the skull to the right-most side of the skull (ear to 
ear).  The sagittal suture occurs where the two parietal bones meet.  It extends 
from the middle of the head to the back.  The lambdoid suture is found where 
each parietal bone meets the occipital bone.  This suture extends across the 
back of the head horizontally.  The suture joints are synarthroses (joints having 
little or no movement).  During childbirth, they are flexible enough to allow the 
skull bones to overlap and absorb mechanical stresses as the baby passes the 
birth canal, avoiding damage to the brain (Bronfin, 2001).  All four sutures are 
very important to the growth of the skull and the brain in the early stages of life.  
The patency of these sutures allows brain expansion and formation of the 
neurocranium (Levi et al., 2012).  If fusion occurs prematurely — before birth or 
at birth — between the sutures, the growth of the neurocranium and brain will not 
proceed correctly because the centers of growth in the skull are ossified (in other 
words, they have become closed).  Such a condition is termed craniosynostosis.  
It is the premature fusion of one or more of the sutures, which are spaces or 
gaps between the bones that comprise the human skull.  Surgical intervention of 
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the deformity is the only form of treatment to correct premature suture fusion.  If 
the deformity is not corrected, it will worsen, threatening both the aesthetics and 
functional components of the skull of the child.   
     Nonsyndromic synostoses, those occurring without syndrome, are the most 
prevalent form of the craniosynostosis abnormality, affecting the coronal, sagittal, 
metopic, or the lambdoid suture or occurring through a combination of the 
sutures.  Normal development of the skull (calvarium) is dependent on skeletal 
bones and synchronized expansion of the brain.  Interactions between the bone 
plates of the skull, brain, suture mesenchyme, and outer covering of the head, 
the dura mater, allow for proper skull growth.  It is not known which interactions 
are affected in the calvarium that lead to the craniosynostosis phenotypes in 
infants.  Many mouse and rabbit studies have been conducted to understand this 
condition to a better degree, but suture biology is yet largely uncertain.  The 
exact causative pathways that lead to the condition remain to be discovered and 
thoroughly understood.  
     Research studies focusing on potential causes of nonsyndromic premature 
suture closure suggest a variety of factors that could be contributing to the 
diseased state, including hereditary, environmental, and/or biomechanical 
factors.  Extensive research has been done in studying the mutations in proteins 
or transcription factors found in craniosynostosis-diseased infants.  Causative 
mutations in the fibroblast growth factor (FGF), transforming growth factor beta 
(TGFß), and twist (TWIST1) families as well as runt-related transcription factor 2 
(RUNX2), osteoblast-specific signaling proteins and transcriptions factors (TFs) 
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have each been identified individually in studies using nonhuman models and 
have been linked to craniosynostosis pathology (Connerney et al., 2008 and 
Morriss-Kay et al., 2005).  Of particular interest to the study researched here is a 
novel zinc-containing transcription factor, osterix, which is essential for osteoblast 
differentiation and bone formation and has not been investigated previously in 
human tissue.  
     Osterix is a transcription factor (Sp7) fundamental for osteoblastogenesis and 
bone formation in mice (Zhu et al., 2012 ).  Null mouse mutants that lack osterix 
will die just hours after birth because there is a deficiency in intramembranous 
and endochondral ossification in their bodies (Baek et al., 2009).  The 
consequence of death is indicative of the significance of osterix and its role in 
vertebrate bone formation.  Genomic studies also show that osterix is 
responsible for bone density in humans (Zhu et al., 2012).   
Osterix-expressing cells produce Wnt protein and respond to Wnt 
signaling (Tan et al., 2014).  Wnt represents both a signaling molecule and a 
signaling pathway and Wnt critically regulates bone development.  It has been 
shown that, if Wnt secretion in vivo is inhibited, inappropriate bone differentiation 
and diminished bone proliferation take place along with a reduction in Wnt 
signaling.  Consequently, osterix-expressing cells produce Wnt proteins that 
induce Wnt signaling responses regulating proliferation and differentiation of 
bone (Tan et al., 2014).  Furthermore, recent craniosynostosis research 
conducted at the University of Pittsburgh studied development of the skull bones 
of mice in response to increased Wnt signaling  (Szabo-Rogers et al., 2014).  
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The work found that differentiation of osteoblasts and osteogenesis were 
increased in the mouse frontal bones (Szabo-Rogers et al., 2014).  These 
findings are very important to this present craniosynostosis study because they 
suggest that, if osterix inactivation can lead to delayed osteoblast maturation and 
reduced bone formation in mice, perhaps the overexpression or up-regulation of 
the osterix transcription factor can affect Wnt signaling.  This possibility could 
lead to increased osteoblast differentiation and formation of bone.  In this 
manner, osterix can play a significant role in early vertebrate suture formation.  
 
                     
  
 
 
 
Figure 1:  A schematic diagram showing that Wnt 
signaling occurs after the expression of osterix for 
mature osteoblast differentiation (Day and Yang, 
2008). 
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     The goal of this project is to investigate the morphology, structure, and 
biochemistry of fused suture sites by using light microscopy, histology and 
immunohistochemistry (IHC).  The specimens to be investigated are affected 
sagittal synostosis tissues and unaffected, open coronal tissues (controls) from 
infants of different ages.  For histology, various stains were utilized to facilitate 
microscopic study and identification of cellular components and arrangement of 
cells inside the diseased craniosynostosis and normal samples.  The stains were 
also applied in some cases to provide biochemical information about the 
samples.   
     Toluidine blue was the principal stain used.  It highlights nuclei acids such as 
DNA and RNA because it is a basic thiazine metachromatic dye with high affinity 
for acidic tissue components.  As such, toluidine blue can distinguish between 
tissues, in this case, the scaphocephaly (sagittal synostosis) and open sutures 
(control).  Hematoxylin and eosin was another stain used in this analysis.  
Hematoxylin stains nuclei of cells a deep blue color and binds to basophilic 
substances.  The counterstain, eosin, binds to acidophilic substances such as 
proteins and cytoplasmic material and turns them red or pink.  Compared to a 
single stain, counterstains provide better visualization of cells and cell structures.  
A picrosirius red and alcian blue stain was also applied.  Picrosirius red allows 
histological visualization of both Type I and II collagen, whereas alcian blue 
stains acidic polysaccharides, for example, glycosaminoglycans in cartilaginous 
bones.  
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     IHC examination of osterix transcription factor was conducted in the diseased 
tissues.  IHC is a method of applying antibodies for identifying proteins specific to 
a histological sample, in this case the affected and normal sutures.  By using IHC 
methods, the identification and the presence or location of the osterix 
transcription factor in tissue sections were made through antibody binding to this 
protein.  These histological and IHC studies have demonstrated thorough 
investigation of the tissues in question and provided scientific insight into the 
pathology.   
 
Material and Methods 
     Cranial suture specimens were obtained from craniosynostosis patients who 
underwent corrective surgery at Akron Children’s Hospital, Akron, OH.  Affected 
and normal tissue from the skull were collected and used for research purposes 
in compliance with Hospital regulation and approval from the parent(s) of the 
patients.  Sagittal suture specimens from three different patients were collected 
over the course of two years (2013-2014).  The ages of the patients were two 
(Specimen 3) and four months (Specimen 4) with one age unknown (Specimens 
1 and 2).  All patients suffered from nonsyndromic craniosynostosis and were 
sporadic (unpredicted) cases.  Specimens 1-2 were taken in surgery at the Akron 
Children’s Hospital in May, 2013, and placed in 10% neutral buffered formalin 
(NBF, VWR, Radnor, PA) at 4°C until research studies were begun two months 
later in the Department of Polymer Science at the University of Akron.  Specimen 
3 was obtained in July, 2013, and also stored in NBF at 4°C until histological 
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analyses were performed in November of the same year.  Specimen 3 was 
obtained from a male, three-month-old child.  Specimen 4 from a four-month-old 
male was received in April, 2014, and stored in NBF at 4°C until histological 
analyses were conducted weeks later.  
Histological Analyses  
     Sample dimensions and location.  Specimens 1-4 were each of different 
sizes and shapes obtained from surgery. They were measured in length and 
width as 4 cm X 0.5 cm, 2 cm X 0.5 cm, 12 cm  X 5 cm, and 9.5 cm X 3.5 cm, 
respectively.  Specimens 1-4 were all sagittal synostoses; specimen 3 also 
contained open coronal and lambdoid sutures; and specimen 4 contained an 
open coronal suture.  The open coronal and lambdoid sutures in specimens 3-4 
were unaffected by the synostosis and served as experimental controls to the 
affected, closed (fused) sagittal regions.  
     Based on the tissue appearance and its hardness, specimen 1 was 
subdivided with a scalpel blade into three regions: ossified, partially ossified, and 
lacking ossification.  Specimen 2 was similarly divided, but only into ossified and 
partially ossified regions because of its short length. Specimen 3 was divided into 
five areas of interest, sagittal anterior and posterior (partially ossified), sagittal 
center (ossified), and a coronal and lambdoid region.  Specimen 4 was cut into 
ten areas, six sagittal and four coronal.  Of the sagittal sutures, three adjacent 
regions (anterior, central, and posterior) were themselves subdivided equally into 
anterior and posterior portions.  Of the coronal sutures, two opposing regions 
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were each subdivided equally into medial and lateral portions.  Images of some 
of the specimens are shown below. 
 
      
      Fixation and decalcification.  Specimens 1-4 were each fixed in 10% NBF 
at 4°C.  Specimens 1 and 2 were fixed for approximately two months and 
specimens 3 and 4 were fixed for 4 months and 1 month, respectively.  
Specimens were then divided using a scalpel blade (Specimen 1 and 2) or a 
Dremel Rotary Tool (Bosch Corp., Stuttgart, Germany) (Specimen 3 and 4) into 
their individual parts based on sample hardness and appearance.  Following 
fixation, all specimens were divided as described above.  NBF solution was 
Figure 2:  Photographs illustrating general overview of specimen 1 (upper left 
panel), specimen 2 (lower left panel), specimen 3 (upper right panel), and 
specimen 4 (lower right panel) obtained following surgery.  Samples were later 
subdivided and processed.  
 11
removed from all divided specimen samples with deionized water (DI H2O). 
Three washes, ten minutes each, were used with a rotary shaker (Rotoshaker 
Genie, Scientific Industries, Bohemia, NY).  After the final wash was finished, 
70% ethanol (Cat. No. 2701, Decon Laboratories, Inc., King of Prussia, PA) was 
added to the containers holding the several divided specimen samples.  
Containers were stored in a 4°C refrigerator until the following day when the 
washes were repeated.  Samples were decalcified initially in 100% Immunocal 
(Decal Chemical Corp., Sufferin, NY) for 24 (samples from Specimens 1 and 2) 
or 72 hours (samples from Specimens 3 and 4) on the rotary shaker at room 
temperature.  Hardness of each tissue sample was detected with a needle and 
samples were decalcified further if they were hard.  To complete the 
decalcification process, a 50:50 solution of Immunocal and NBF was prepared, 
and samples were transferred from 100% Immunocal to the 50:50 solution.  
Samples from Specimens 1-2 and 3-4 were additionally decalcified 1.5 and 24 
hours, respectively.  Samples were tested again with a needle to detect hardness 
of the suture tissue and were found to have decalcified adequately.  To remove 
Immunocal-NBF solution, three DI H2O washes, fifteen minutes each, were done 
using the rotary shaker and three, 70% ethanol washes, fifteen minutes each, 
removed the remaining water.  The samples were stored in the last ethanol wash 
at 4°C.  
     Processing.  The processing steps were identical for all samples.  Samples 
were removed from the 4°C refrigerator and from their containers having 70% 
ethanol.  Samples were placed into plastic cassettes, which were labeled to 
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identify their individual tissue and its corresponding region.  The cassettes were 
next placed into a tissue-processor (Leica Asp 300s, Buffalo Grove, IL) and left 
over the weekend to complete the processing cycle of a series of automated 
washes in preparation for sample embedding.  
     Embedding.  The embedding procedure was the same for all samples.  After 
processing, individual tissues were quickly removed from the processor and 
immediately embedded into paraffin wax blocks using a tissue embedder (Leica 
EG 1150C, Buffalo Grove, IL).  Samples were embedded in wax molds with their 
anterior portion (in relation to the anatomy of the skull) at the bottom of the mold.  
This orientation was necessary so that, when serial sections were prepared, they 
would be cut anterior-to-posterior and their regional identity would be recognized.  
The thinnest dimension of each sample was also oriented toward the bottom of 
the mold.  After wax was poured over the samples, embedded molds were set on 
a cooling plate (Leica EG 1150C, Buffalo Grove, IL) to allow the wax to solidify.  
After ten minutes, hardened paraffin wax blocks containing the samples were 
stored in a -20°C freezer to allow the blocks to harden. 
     Sectioning.  Samples were all treated identically when sectioning.  Wax 
blocks were removed from the -20°C freezer and placed in a -80°C freezer to 
supercool wax blocks overnight before sectioning.  This procedural step helped 
harden the blocks and aided sectioning.  Wax blocks were then removed from 
-80°C and were sectioned using an automated microtome (Leica RM 2255, 
Buffalo Grove, IL).  Sections were cut at 6 µm thicknesses using a tungsten 
carbide blade.  Wax blocks were trimmed and then serial (consecutive) sections 
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were prepared.  Surface decalcification was utilized for blocks that produced 
shredded sections.  Sections were floated on a water bath (Leica HI1210, 
Thermo Scientific, Portsmouth, NH) and then transferred to Superfrost Excell 
slides (Thermo Scientific, Portsmouth, NH).  Slides were labeled accurately and 
allowed to dry in air overnight in a vertical position.   
     Staining.  Various basic stains were used to highlight and examine structural 
components of the suture tissue.  The stains utilized in this study were 
hematoxylin and eosin, toluidine blue, pircosirus red, and pircosirus red 
counterstained with alcian blue.  
     Preparation of Stains.   Hematoxylin and eosin (H&E) stain was applied to 
samples obtained from specimens 1 and 2 (Figure 2).  Hematoxylin is a stain 
used for nuclear detail, while eosin serves as a contrasting counterstain for 
extracellular substances.  A progressive staining procedure was used in which 
slides were stained with hematoxylin, rinsed, and then counterstained with eosin.  
The following materials were used to prepare the H&E stain:  Hematoxylin, eosin 
Y, weak acid deionized H2O (0.3% HCI), and weak basic NH4OH (0.5% NH4OH; 
also known as bluing agent).  These reagents were mixed over a stir plate and 
then stored at room temperature.   
    Toluidine blue (T-blue) stain was used for samples obtained from specimens 1 
and 2 in this study.  Toluidine blue is a thiazine metachromatic dye that stains 
acidic tissue components.  This dye stains nucleic acid material blue and 
polysaccharides purple.  For this stain 0.1% toludine blue solution was made. 
Toluidine blue powder (FisherBiotech, Fair Lawn, N.J.) was measured to 0.5 gm 
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and 500 mL of milliQ water was added.  Stain was then mixed over a stir plate 
and stored at room temperature.  
     Picrosirus red (PSR) was another stain utilized in this study.  Staining was 
performed on samples obtained from specimen 1 and 2.  PSR is intended for 
visualization of collagen fibers (types I and II).  Collagen stained with PSR is 
visible by both normal and polarized light microscopy (birefringence).  PSR stains 
collagen fibers red and cell cytoplasm and muscle fibers yellow.  For preparation 
of this stain, Sirius red F3B (C.I. 35780, Pfaltz and Bauer Inc., Waterbury, CT) 
was measured to 0.5 gm and 500 mL of an aqueous solution of picric acid was 
added and mixed on a stir plate.  Acidified water was also prepared by 
measuring 5 ml of acetic acid and adding it to 995 mL of deionized water.  
     Picrosirus red and alcian blue stains were utilized for samples obtained from 
specimen 3 (Figure 2).  The purpose and preparation of picrosirus red stain are 
explained in the previous paragraph.  Alcian blue stain is intended for 
visualization of sulfated and carboxylated acid mucopolysaccharides and sulfated 
and carboxylated sialomucins (glycoproteins).  A 3% glacial acetic acid solution 
was prepared by adding 9 mL of acetic acid to 300 mL of deionized water.  The 
3% acetic acid solution was added to 3 gm of Alcian Blue 8GX powder (Sigma 
Chemical Co., St. Louis, MO), creating a 1% alcian blue solution.  The solution 
was then mixed over a stir plate and pH adjusted to 2.5 using acetic acid.  Stain 
was then stored at room temperature.  
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     Staining procedure.   
     Deparaffinizing, clearing and hydration.  All prepared slides were placed in an 
oven at 58°C for a minimum of 2 hr to deparaffinize sections.  Three changes of 
xylene (EK Industries, Joliet, IL) washes, 5 min each, were carried out in the 
fume hood.  A change of 100% ethanol for 2 min was then done, followed by a 
95% ethanol wash for 2 min.  Two changes in 70% ethanol were done for 2 min 
each.  Distilled water rinse for 2 min followed.  
     Staining process for hematoxylin and eosin.  Slides were stained in filtered 
hematoxylin for 5 min and then destained in 0.5% HCI (freshly prepared in water) 
for 20 sec.  Slides were then briefly rinsed in running deionized water and slides 
were dipped in water five times.  Slides were then washed in 0.5% ammonium 
hydroxide (bluing agent) for 30 sec, which was also freshly prepared.  Slides 
were then washed in 95% ethanol for two min.  The counterstain eosin Y was 
then applied for 1 min.  
     Staining process for toluidine blue.  Slides were immersed in freshly filtered 
0.1% T-blue stain for 1 min.  Slides were then dipped in freshly distilled water five 
times.  
     Staining process for picrosirius red.  Slides were placed in a staining dish 
containing picrosirius red stain for 1 hr.  Slides were then washed in two changes 
of acidified water for 2 min each.  
     Staining process for picrosirus red and alcian blue.  Slides were placed in 
0.5% acetic acid solution for 10 min, removed, and then placed in 1% alcian blue 
stain (pH 2.5) for 10 min.  Two washes of 0.5% acetic acid solution followed for 3 
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min each.  Slides were placed into a staining dish containing 0.5% picrosirius red 
counterstain for 1 hr.  Two 0.5% acetic acid rinses (ten dips) were then 
performed. 
     Dehydration, clearing and mounting slides.  After completing the staining 
process, two changes of 95% ethanol for 1 min each were conducted.  Two 
changes of 100% ethanol for 1 min each followed.  Slides were put through three 
xylene washes (5 min each) before being mounted and coverslipped with DPX 
Mounting Medium (Cat. No. 13512, Electron Microscopy Sciences, Hatfield, PA).  
Slides were allowed to dry overnight in a horizontal position before microscopic 
examination.  
      Immunohistochemistry for paraffin-embedded tissue sections (IHC).  
This technique was applied to samples obtained from specimen 4 (Figure 2).  
IHC detects an antigen (protein of interest in cells) in tissue sections by antibody 
binding.  IHC provides the identification of the location and distribution of specific 
proteins in the tissue section.  In this research analysis, the osterix protein was 
studied by IHC.  
     Deparaffinizing, drying, rehydration and fixation.  Prepared slides were placed 
in an oven at 58°C for 4 hr to deparaffinize the sections.  Three changes of 
xylene (EK Industries, Joliet, IL) washes, 10 min each, were carried out in a fume 
hood.  Two changes of 100% ethanol for 5 min each were done.  Slides were 
then placed into 95% ethanol twice for five minutes each.  Slides were then 
removed from solution and placed on a countertop and dried with a heat gun 
(cold air setting) for 10 min.  The heat gun setting was changed to hot air and 
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slides were dried for additional 10 min.  The cold-hot drying was repeated for 5 
min each to complete this four-process sequence.  Two changes of milliQ water 
followed for 5 min each to rehydrate the sections.  Slides were then placed in 
10% NBF for fixation overnight at room temperature.  
     Epitope (antigen) retrieval.  Slides were removed from NBF solution and two 
changes of deionized water, five minutes each, were made.  Two 100% 
Immunocal washes (1 hr each) followed.  Again, slides were washed twice with 
deionized water for 5 min each.  Slides were then placed into a dish containing 
epitope retrieval solution (see below) and the dish was placed in a 60°C water-
bath for 72 hr. 
                                              
 
The water in the bath was checked during the 72 hr time frame to maintain its 
appropriate level.  Epitope retrieval solution was prepared by adding 1.47 gm of 
sodium citrate, 0.37 gm of ethylenediaminetetraacetic acid (EDTA), and 0.25 mL 
Figure 3:  Illustration of slides (blue) in a covered staining dish (dark grey 
box) containing epitope retrieval solution.  The slide box sits in a water 
bath, heated to 60°C, within a larger box (light grey).  The blue line in the 
illustration indicates the water level.  
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of Tween 20 to 500 mL of H2O and with stirring on a stirplate.  The pH was 
adjusted to 6-6.5. hydrogen chloride.   
     Application of primary antibody.  Slides were cooled by adjusting the water 
bath to 20°C.  Slides were maintained in a hydration state for further processing. 
Slides were washed twice with phosphate-buffered saline (PBS) solution for 5 
min each.  Slides were removed from PBS and placed individually on a 
countertop.  Two-three drops of Background Buster Blocking Agent (Innovex 
Biosciences, Richmond, CA) were immediately applied to the slides for 30 min to 
block endogenous tissue sites of possible antibody binding.  The blocking agent 
was removed quickly by drainage from the slide and primary osterix antibody 
(dilution factor: 50 micrograms of antibody to 1 mL of diluent) was applied.  Other 
slides were processed in the same manner except that they were treated with 
Tris-buffered saline and Tween 20 (TTBS) in place of the osterix antibody (these 
slides served as negative controls).  Slides were left overnight at 4°C.  
     Peroxide/Methanol block, DAB, hematoxylin staining, and mounting slides. 
Three washes of TTBS were applied for 5 min each.  ImmPress Reagent 
Peroxidase (2nd antibody) (Vector, Burlingame, CA) was applied to all slides for 
30 min.  Again, three washes of TTBS identical to those noted above were 
performed.  A 30% methanol hydroxide and 0.3% hydrogen peroxide (H2O2) 
block for applied for 10 min.  Three TTBS washes followed for 5 min each.  3,3-
diaminobenzidine (DAB) peroxidase was applied to slides for up to 2 min.  Once 
brown coloration was seen on slides, DAB was removed and slides were quickly 
placed in a dish containing PBS solution.  To prepare DAB peroxidase, a 
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MaxTag DAB tablet (Rockland Immunochemicals, Inc., Gilbertsville, PA) was 
added to a non-light-penetrating test tube and PBS was added to the 7 mL mark 
of the tube.  DAB was dissolved thoroughly in PBS solution and stored on ice 
until needed for use.  Immediately prior to application, 2-3 drops of H2O2 
(activator of DAB) were added to the test tube and the tube was shaken.  Slides 
were then washed with PBS two times for 5 min each.  Mayers hematoxylin (Cat. 
#26252-01, Electron Microscopy Sciences, Hatfield, PA) was used to stain slides 
for 1 min.  Slides were placed under running deionized water for 4 min.  Slides 
were then dipped in bluing reagent ten times consecutively.  The following 
alcohol washes were then used in order:  two 70% ethanol washes, two 95% 
ethanol washes and two 100% washes.  Each wash was timed for 2 min. Three 
xylene washes were then used, each 5 min.  Slides were mounted and 
coverslipped and left to dry in a vertical position.  
     Microscopy.  In this study, an Olympus 1X70 (Olympus America, Center 
Valley, PA) light microscope combined with Olympus MicroSuite Software for 
Imaging Applications was utilized to view sections.  Slides were cleaned with a 
KimWipe (Kimberly-Clark Professional, Roswell, GA) and then placed on the 
microscope stage. The large and small coarse focus knobs of the microscope 
were adjusted until the image appeared clear.  Adjacent areas of each slide were 
scanned and imaged section-by-section and saved onto a USB drive.  Images 
were taken at 4X magnification and a scale bar was superimposed on each 
image.  Saved images were stitched together using Microsoft Image Composite 
Editor and montage images were compiled and stored.  Sufficient overlap 
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between images was maintained for proper stitching of consecutive images. 
Stitching images in this manner helped maintain clarity of the full section and its 
resolution.   
 
Results  
     Basic dyes such as T-blue, H&E, and PSR were used to assess 
craniosynostotic diseased tissue obtained from the specimens of interest, in this 
case specimens 1 and 2.  Results indicated different patterns of morphology 
between specimen areas that were identified as ossified, partially ossified, and 
absent of ossification.  These regions were classified based on their position and 
location in relation to the anatomy of the skull before being dissected and 
sectioned.  The ossified regions of specimens 1 and 2 were osteogenic centers 
that had undergone premature fusion of the skull.  These center-ossified regions 
were of particular interest in this study and therefore they were compared to the 
other two skull areas (partially ossified and absent of ossification) to study 
regional differences in bone anatomy.  Figure 4 shows that bone in the ossified 
skull region had more marrow space in comparison with it counterparts and also 
demonstrated that osteocytes trapped in lacunae were more numerous and 
indicative of ossification in these samples.  Below are images of the various 
stains of specimens 1 and 2 showing gross morphology and anatomy of the 
affected suture tissue.  
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Figure 4:   T-blue-stained images of specimen 1 depicting three different regions 
of the sagittal suture from a patient of unknown age or gender.  Top left:  There 
is little or no ossification in this part of the specimen. Top right:  Another area of 
the same specimen is partially ossified as determined by its hardness.  Bottom 
center:   A third area of the specimen is ossified, again determined by its 
hardness.  T = Trabeculae, M = Mineral.  Scale bar in all images = 500 µm. 
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Figure 5:   T-blue stained images of specimen 2 (obtained from a patient of unknown age 
and gender) depicting a partially ossified (left) and ossified region (right) of the suture.  
Both images show the fully transverse suture region.  Right image is a series of separate 
photomicrographs that have been stitched together with ICE Software.  Scale bars in left 
and right image are 500 µm and 1 mm, respectively. 
 
Figure 6:   H&E-stained images of Specimen 1 taken from different areas of suture 
tissue.   The left, middle, and right images, each stitched from numerous 
photomicrographs, display an area absent of ossification, a partially ossified region, 
and an ossified region, respectively.  Scale bar in all images = 1 mm. 
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Figure 7:   H&E-stained images of specimen 2 illustrating a partially ossified (left) and an 
ossified region (right) of the suture tissue.  The left side of the ossified image faces the 
dura mater of the skull, while the right side faces the skull periosteum side.  Scale bars 
in left and right image are 500 µm and 1 mm, respectively.  
 24
 
 
      
     In all stained ossified, closed regions obtained from sagittal sutures, 
mineralized bone trabeculae were more apparent than in stained partially ossified 
regions and regions absent of ossification.  Partially ossified regions and regions 
absent of ossification displayed fibrous tissue having little or no trabecular 
formation, an observation indicating that areas have not fully undergone 
intramembranous ossification.  Trabecular bone, also known as cancellous bone, 
Figure 8:   PSR-stained images of specimen 1 showing particular areas of 
suture tissue, an ossified region (top left), a partially ossified region (top 
right) and an area lacking ossification (bottom center).  Scale bar in all 
images = 500 µm. 
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is usually highly vascularized, a fact which explains the large marrow spaces in 
the ossified regions compared to the other two regions (Figure 8).  Flat bones, 
such as those of the skull, receive a superficial blood supply from the periosteum, 
which is needed for proliferation of bone cells.  This additional fact could be the 
very reason that many marrow spaces are present in the ossified regions 
indicative of blood vessels and capillary blood supply needed for growth.   
     In Figure 7, the ossified region displayed an interesting pattern at its 
periosteum side.  The mineralized bone trabeculae appeared to follow a 
particular arrangement and run parallel to each other.  The architecture and 
arrangement of the bone tissue seemed unique in the sense that small-elongated 
holes line the periosteum surface and gradually diminish in size deeper into the 
tissue.  These holes near the periosteal surface of the suture were different from 
the deepest tissue regions where prominent large holes form trabecular bone.  
The reasons for the presence of these two distinct types of holes in the sutures 
are not clear, but the differences between the periosteum and trabecular bone 
could be where underlying premature ossification originated because of 
mechanical stress on the suture tissue. 
     Suture fusion results from intramembranous ossification.  This process 
includes the appearance of an ossification center in the fibrous connective 
membrane region and secretion of bone within the fibrous membrane to form 
woven bone (immature trabecular bone).  Woven bone is later remodeled to 
create lamellar bone (mature bone).  Figure 9 shows both lamellar and trabecular 
bone.  The lamellar bone in this figure appeared organized and stress-oriented, 
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two characteristics of lamellar bone in general.  Moreover, when the ossified 
region of specimen 2 was viewed under higher magnification using a polarized 
light microscope, lamellar organization reflected a repeating pattern of bright and 
dark bands of collagen fiber architecture.  This patterning is suggestive of mature 
lamellar bone present in the tissue sample  (Figure 10). 
 
 
Figure 9:   PSR-stained images of specimen 2 depicting an ossified suture 
region. Left image is a view under polarized light and right image depicts the 
ossified region with normal light microscopy.  Polarization shows presence of 
collagen.  Scale bar in all images = 1 mm. 
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     Picriosirius red, a stain utilized in this study, was applied for histological 
visualization of type I and III collagen fibers.  Under polarized light, collagen 
fibers found in the tissue appeared bright red-orange and green and could be 
distinguished from the non-collagenous background material, which appeared 
black.  Because bone is composed of roughly 30% organic compounds, of which 
collagen constitutes about 90%, the presence of collagen provides the principal 
supporting framework of the suture.  
Figure 10:  Ossified region of specimen 2 viewed using polarized light 
microscopy.  Presence of collagen is indicated by birefringence (bright 
yellowish-red and green appearance) in this closed suture tissue.  There is a 
repeating pattern of bright and dark bands in some areas of the section 
(arrows).  Scale bar = 500 µm. 
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     Specimen 3, obtained from a two-month-old child, was divided into five areas 
of interest, sagittal anterior and posterior (partially ossified), sagittal center 
(ossified), and a coronal and lambdoid region, and was stained using picrosirius 
red and alcian blue to assess tissue morphology.  This stain was useful for 
visualizing the suture site and its surrounding areas where bone was thought to 
be deposited.  
 
 
 
 
Interestingly, the sagittal posterior (partially ossified) region of specimen 3 
displayed an organized layering pattern on its periosteum side, while trabecular 
bone appeared deeper into the suture (toward the dura mater).  The tissue also 
exhibited a region where it seemed that parietal bone plates were meeting and 
undergoing fusion.  This feature can be seen by a distinctive gap in the tissue 
(Figure 12).   
Figure 11:  Sagittal posterior, partially ossified region of specimen 3 stained 
using picrosirius red and alcian blue stain and viewed using light microscopy. 
The area depicts a possible fusing suture shown by the prominent gap found 
in the tissue and indicated by the arrow.  There is also the presence of several 
thin, parallel layers of cortical bone adjacent to trabecular bone.  Scale bar = 1 
mm.  
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     At the microscopic level, flat bones of the skull have outer compact bone 
layers, one layer toward the periosteum and the other toward the brain.  
Cancellous (trabecular) bone occupies the center region between the two layers. 
The results obtained from picrosirus red and alcian blue staining demonstrated 
these two types of bone, trabecular and compact, present in the cranial suture 
tissue (Figure 12).  The compact bone could be forming at the site of suture 
fusion, a possibility that is supported by results shown in Figure 13. 
 
 
Figure 12:  This figure depicts photomicrographs obtained from a surgical sample of 
a male, three-month-old child (specimen 3) and stained with picrosirius red and 
alcian blue.  The first, second, third, and last micrographs depict a coronal, a sagittal 
center (ossified), a posterior (partially ossified) and a lambdoid suture region, 
respectively.  Note that an anterior sagittal suture is not depicted.  Scale bar = 1 mm.  
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Figure 13:  Enlargement of Figure 11, the sagittal posterior, partially ossified suture 
region displaying a layering pattern of cortical bone (C) near the periosteum surface 
with a possible open, unfused area (S) in the center of two opposing parietal bone 
plates (P).  Trabecular bone (T) is deposited deeper into the tissue.  Scale bar = 
500 µm. 
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     The gap that appeared within the layered cortical bone evidently depicted an 
area of the suture tissue that was open and undergoing ossification (Figure 11).  
It is presumed that the suture joint would eventually ossify when parietal plates 
met from opposing sides.  Once the bone ossified, the suture would disappear 
and would leave no trace of the suture site.  This open region normally provides 
continued growth of the skull but such regions are diminished or lost in premature 
suture fusion, as previously noted.  Once a suture site disappears, it becomes 
impossible to identify its location in the ossified tissue.  This result explains why 
suture sites cannot be identified in other closed areas of the surgical specimens 
examined in this study.  
 
Figure 14:  Image taken from a lambdoid suture region showing periosteum 
surrounding the outside of the skull bone (toward the skin), as indicated by the 
arrow.  The periosteum is a layer of dense connective tissue and is fibrous 
externally (toward the skin) but becomes more vascularized and cellularized 
near the bone tissue.  Scale bar = 500 µm. 
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     Trabecular bone is known to be very sensitive to external forces and provides 
the remarkable strength of the skull.  This type of bone is extremely porous and 
forms the inner area of the skull bones, whereas compact (cortical) bone forms 
the outer layers.  This description agrees with the histological results obtained in 
this study using picrosirius and alcian blue staining.  All areas of interest, sagittal 
anterior and posterior (partially ossified), sagittal center (ossified), and a coronal 
and lambdoid region, displayed this type of tissue arrangement, where the 
periosteum side of the samples contained cortical bone and inner bone layers 
were trabecular (Figure 12).  
     Osterix, a zinc-finger containing transcription factor essential for forming bone, 
was identified and localized in cranial suture tissue in specimen 4.  Osterix is 
specifically found in the nucleus of cells undergoing the transition between 
mesenchymal stem cells and osteoblasts, as it is a protein that plays a role in the 
transcription of other important proteins vital to bone development and the 
differentiation of mesenchyme cells into osteoblasts.  Figures 15 -18 are images 
of osterix immunohistochemical staining of a posterior, sagittal suture region from 
a four-month-old male.  The staining demonstrates the presence of osterix in 
cells transition to osteoblasts of this developing suture tissue.  Counterpart 
sagittal suture sections treated without primary antibody to osterix were negative 
controls and they showed no specific staining for osterix (Figures 15 -16).  Such 
negative controls verify that the immunostaining of osterix is real and not the 
result of a nonspecific reaction.  
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     In detail, immunostaining results indicated the presence of osterix in cells 
lining the surfaces of trabecular bone and the absence of osterix in cells of 
cortical bone (Figure 15).  3,3’-diaminobenzidine (DAB) staining was present also 
within posterior portions of the trabecular bone of sagittal sutures, a result 
indicative of osterix and thus osteoblast activity in this suture region (Figure 15).  
 
 
     On comparison of negative control test slides and experimental slides, 
mesenchymal stem cells (MSC) were found to be present in the marrow space in 
both (Figure 16).  In the negative controls, the MSCs stained blue with 
hematoxylin, whereas in the experimental slides MSCs stained brown (DAB 
staining) as well as blue, an observation that verified the presence of osterix. 
This finding was notable in that it supported the notion that intramembranous 
Figure 15:  Immunohistochemistry of osterix-stained images from a four-
month-old male (specimen 4), showing posterior portions of a sagittal suture.  
The image on the left shows a negative control test area where DAB staining 
for osterix is absent because no primary antibody was applied to the tissue.  
The image on the right shows a region of the posterior, sagittal suture reacted 
with primary antibody.  DAB staining (brown) is present in this suture region 
within osteoblasts lining the trabecular bone (arrows) and within cells found in 
marrow spaces (arrowheads).  Scale bar = 500 µm. 
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ossification was occurring.  MSCs are progenitor cells that may become 
osteoblasts under certain conditions, and osterix staining demonstrated the 
transition from MSCs to osteoblasts in the marrow spaces.  These osteoblasts or 
their precursors appear to form a nidus, a dense cluster of cells within the 
marrow spaces. Differentiated osteoblasts, stained brown for osterix, are lining 
the trabecular surfaces of the suture (Figure 16).  
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Figure 16:  Posterior portions of a sagittal suture from a four-month-old male stained 
without (upper panel) and with (lower panel) DAB to demonstrate osterix.  Images 
are taken from the same region of the specimen but different areas within the tissue.  
Aggregation of mesenchymal stem cells appears in the marrow space as can be 
seen by the cluster of cells in the center of the tissue.  The nidus of aggregated cells 
in the marrow space in the lower panel is composed in part by DAB-stained cells 
transitioning from MSCs to osteoblasts.  Differentiated osteoblasts line the trabecular 
bone as indicated by the arrows.  Scale bar = 500 µm. 
Figure 17:  Posterior portions of a sagittal suture from a four-month-old 
male stained with DAB to demonstrate osterix.  The image shows osterix 
staining in the marrow spaces of the tissue.  T = trabecular bone.  M = 
marrow space.  OSX = osterix stain.  O = osteocytes.  Scale bar = 500 µm. 
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      Overall, the novel finding of osterix in the suture tissue from specimens of 
craniosynostosis supports the concept that osteoblast activity and bone formation 
occur in or around the closing suture.  As a transcription factor, osterix acts as a 
marker for osteoblast differentiation and proliferation in postnatal bone formation 
of the skull.  Additionally, the absence of osterix expression in cortical bone and 
the presence of osterix in cells lining the surfaces of trabecular bone as well in 
cell aggregates within trabecular bone marrow spaces are new findings.   
 
Discussion 
     Craniosynostosis, the premature fusion of the suture(s) in pediatric patients, is 
a pathological condition that remains ambiguous and incompletely understood.  
C 
T 
Figure 18:  Posterior portions of a sagittal suture from a four-month-old male 
stained with DAB to demonstrate osterix.  The DAB stain remains particular to 
the osteoblasts lining the trabecular bone region and is absent in cells within 
cortical bone.  C = cortical bone.  T= trabecular bone.  Scale bar = 500 µm. 
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Although studies with syndromic (with known condition) craniosynostosis have 
identified genetic factors associated with this condition, little is known about the 
nonsyndromic form of craniosynostosis.  This research study intended to 
understand more thoroughly cranial suture biology and the deformational factors 
leading to the diseased phenotypes in nonsyndromic forms of craniosynostosis.  
Results of gross morphology and histology of affected suture tissues were 
obtained to provide structural and architectural information about the specimens.  
In addition, immunohistochemistry of osterix yielded the preliminary result that 
this transcription factor was associated with cells in aggregates within marrow 
spaces of the tissues as well cells lining the trabecular areas of the sutures.  The 
presence of DAB-positive cells in marrow spaces provides evidence that MSCs 
transition to osteoblasts in these trabecular bone regions.  Cells lining the 
trabecular suture areas are also DAB-positive and here they are functional, 
differentiated osteoblasts.  Further, osterix expression is absent in cortical bone. 
The findings of osterix in osteoblasts at the trabecular surfaces of the sutures 
and in cell aggregates within marrow spaces of trabeculae have not been 
reported previously.  These results provide new insight into craniosynostosis and 
cranial suture biology. 
     Future studies will examine osterix immunohistochemistry more completely to 
understand the formation of trabecular bone in additional sagittal sutures affected 
by craniosynostosis as well as synostoses in other bones of the skull.  Efforts will 
also be made to quantitate expression of osterix in diseased tissue, so 
comparisons could be made to control tissue regions (normal suture areas 
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extracted alongside fused regions during surgery).  If expression levels of the 
osterix protein were abnormally higher in fused suture regions compared to that 
of open regions, then it might be concluded that high osterix expression plays a 
role in suture closure.  If such were the case, proteins upstream of osterix would 
also be analyzed and would include Indian Hedgehog (IHH), Wnt, and Runx2.  
These proteins might themselves have downstream effects on osterix.  A high 
level of osterix expression could possibly influence the rate of differentiation and 
the number of osteoblasts in the suture tissue region leading to bone deposition.  
     As discussed before, the lack or inactivation of osterix can have detrimental 
effects causing severely undeveloped bone anatomy of the skull in mice (Baek et 
al., 2009).  In the present study, results propose that overexpression or 
upregulation of osterix could potentially also lead to detrimental effects resulting 
in overdevelopment and premature fusion of the bone tissue.  Craniosynostosis 
could be one such effect.  Future work will hopefully provide greater insight into 
the etiology of craniosynostosis.  Again, surgical specimens would be collected 
from Akron Children’s Hospital, dissected, processed, embedded, and sectioned 
for analysis.  
     It is already known that osterix knock-out mice fail to form bone but to 
understand further the role of osterix in normal bone development, a mouse 
model could be studied.  One model is the mice affected with Frank-ter Haar 
syndrome, which is known to induce sagittal craniosynostosis (Bendon et al., 
2012).  This mouse model would allow thorough examination of both a fully 
diseased and normal tissue sample from calvaria.  Such a mouse model would 
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overcome the limitation of the present study in which normal sagittal human 
tissue from a perfectly healthy skull of an infant cannot be obtained in any 
surgical instance.  Frank-ter Haar mice, however, could still be used for 
comparison with tissue from normal mouse counterparts.  It is difficult to mimic 
the nonsyndromic form of craniosynostosis in mice because the cause of the 
nonsyndromic form, as its name implies, is unknown and therefore impossible to 
induce in the animals.   
     RNA levels of osterix could be measured in diseased and normal tissue 
through RNA isolation and polymerase chain reaction (PCR) analysis.  If osterix 
RNA expression were statistically different between the diseased and normal 
tissue, then molecular genetics could be used to investigate genes encoding the 
osterix protein in the diseased and normal states.  
     The discovery of osterix in the human craniosynostosis diseased tissue here 
introduces new avenues and possibilities for understanding the condition more 
completely.  It would be interesting to study the molecular and cellular 
mechanisms that govern osterix control of how and when osteoblast proliferation 
and differentiation occur, as these are areas that remain uncertain.  It is known 
that osterix is present in the early stages of osteoblast proliferation and 
differentiation, whereas proteins like osteocalcin, osteopontin and bone 
sialoprotein are mid-to-late stage osteoblast markers.  Thus osterix effects on the 
complete osteoblast pathway (early to final stages) need to be investigated.  
Additional studies addressing the role of osterix in the pathway could provide 
clearer insight about craniosynostosis and possibly other bone pathologies.  
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     The current treatment of craniosynostosis remains traditional surgery (ranging 
from minimal to invasive).  The goal of corrective surgery is to treat the pathology 
once it has already formed.  This surgery allows any pressure on the brain to be 
relieved/removed, provides ample room for the growth of the skull, and can 
improve the appearance of the child.  This condition can be inherited but most 
cases remain sporadic.  Therefore genetic counseling could be recommended to 
those families that are aware of the inherited disorder.  Continued research 
efforts should be made to understand craniosynostosis, so the disease can be 
prevented before it even occurs.  Progress should be made to prevent this 
problem rather than treating it after the fact.  Like folic acid taken as a prenatal 
vitamin during pregnancy to help prevent birth defects of the brain and spinal 
cord, perhaps in the future a similar type of treatment or drug will be 
recommended to pregnant women to prevent diseases like craniosynostosis in 
infants.  
     In conclusion, this study used histological and/or immunohistochemical 
analyses to study nonsyndromic sagittal synostoses as well as patent (normal 
open suture) tissue obtained from the skulls of three pediatric patients in surgery 
from Akron Children’s Hospital.  Histological staining, including toluidine blue, 
hematoxylin and eosin, and picrosirius red counterstained with alcian blue, has 
been performed.  The histological methods provided qualitatively describing 
tissue and cell architectural shapes and gross morphology of surgical specimens. 
Immunohistochemical analyses were also performed to study the presence of 
osterix, and the preliminary results found osterix presence in posterior portions of 
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the sagittal regions of the specimens of interest.  This finding is novel.  Osterix, a 
critical transcription factor in bone, is known to play a vital role in osteoblast 
differentiation and bone formation.  Continued progress in understanding osterix 
gene expression and protein synthesis and secretion will be particularly important 
for gaining information and insight into craniosynostosis.  
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